Login

Pfenex Inc. 3 SEC Filings

Filed On Filing
09 Oct 2020 Form 3: Ligand Pharmaceuticals Inc, 10% owner

Holds 27,034,437 shares of Common Stock

02 Oct 2020 Form 3: Newtyn Management, Llc, 10% owner

Holds 3,850,000 shares of Common Stock, par value $0.001 per share

30 Sep 2020 Form 3: Weiss Asset Management Lp, 10% owner and 2 others

Holds 4,320,055 shares of Common Stock

08 Aug 2019 Form 3: Masuoka Lorianne, Director

No securities owned

19 Mar 2019 Form 3: Brenner Martin, Chief Scientific Officer

No securities owned

04 Mar 2019 Form 3: Marquet Magda, Director

No securities owned

02 Oct 2018 Form 3: Scranton Shawn, SVP, Chief Operating Officer

No securities owned

02 Feb 2018 Form 3: Knudson Susan A., Chief Financial Officer

No securities owned

03 Aug 2017 Form 3: Schimmelpennink Evert B., Director

No securities owned

08 May 2017 Form 3: Olafsson Sigurdur O, Director

No securities owned

08 May 2017 Form 3: Grenfell-Gardner Jason, Director

No securities owned

27 Sep 2016 Form 3: Sandoval Steven S. Sr., Chief Manufacturing Officer

No securities owned

15 Sep 2015 Form 3: Fenton Dennis M, Director

No securities owned

28 Apr 2015 Form 3: Taylor John Mack, Director

No securities owned

03 Nov 2014 Form 3: Chen Hubert C, Chief Medical Officer

No securities owned

25 Sep 2014 Form 3: Campbell Robin, Director

No securities owned

24 Jul 2014 Form 3: Rohn William R, Director

No securities owned

24 Jul 2014 Form 3: Schneider Phillip M, Director

No securities owned

18 Jul 2014 Form 3: Signet Healthcare Partners Accredited Partnership Iii Lp, 10% owner and 1 other

Holds 81,475 shares of Common Stock

17 Jul 2014 Form 3: Liang Bertrand C., Director

Holds 637,980 shares of Common Stock

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support